In September 2020, GlaxoSmithKline plc ("GSK") announced that it had signed new US$2.5bn 364-day and £1.9bn three-year SOFR and SONIA linked RCFs. The facilities were provided by a total of 12 banks on a bilateral basis (with HSBC acting as risk-free rate coordinator). In this spotlight interview, Kam Mahil speaks to those involved in the deal.

The clock is ticking and, as we progress through the final year of LIBOR, key milestones to cease LIBOR lending are rapidly approaching. Regulators across the globe have reiterated that firms cannot rely on LIBOR being published after the end of 2021. They also cannot rely on legislation to solve the transition for them. This live webinar, presented by Kam Mahil and Keith Taylor of the LMA, will provide an update on transition since the previous webinar in September 2020.

Our webinar entitled "Loan market review of the year and key drivers for 2021", which was streamed live on 3 December to over a 1,000 viewers, is now available on demand. It covers, amongst other things: Economic outlook; Review of loan market volumes and structures; Risks and opportunities impacting the loan market in 2021; Changing investor appetite and new sources of liquidity; and Impact of Brexit and Covid-19.